BioClinica expands imaging services in Europe with two new offices

By Zachary Brennan contact

- Last updated on GMT

Related tags: Medical imaging, Medicine, Clinical trial

BioClinica expands imaging services in Europe with two new offices
BioClinica has opened offices in London and Munich to provide its European clients with expanded clinical trial services including medical imaging, site training and support, and eClinical product lines.

The combined space of 1,400 square meters across the two sites will specifically focus on medical imaging services, including an advanced image analysis center for BioClinica’s network of European radiologists and imaging specialists. 

As far as why this additional space may be necessary, John Hubbard, CEO of BioClinica, told “Imaging endpoints and biomarkers are becoming increasingly important as primary and secondary endpoints for demonstrating efficacy and safety in clinical trials. This is reflected in the current growth of the medical imaging sector at approximately 7-10% annually​.” 

Medical imaging can also provide early insight for the diagnosis, prognosis, and progression of complex diseases, which can help sponsors make decisions on trial enrollment and the advancement of pipeline candidates, Hubbard said, noting this is “especially true in the rapidly growing therapeutic areas of oncology, inflammatory disease, musculoskeletal disease, and neurological disorders​.” 

In addition to the imaging services, BioClinica’s eClinical Solutions business will also operate from these two new offices, Hubbard said. “We are seeing a high level of interest in our clinical technology products, including OnPoint CTMS (clinical trial management system) and Compass (intelligent risk based monitoring), designed to help sponsors run faster, more efficient clinical trials​.” 

David Herron, BioClinica’s President of Medical Imaging, Cardiovascular Safety, and Molecular Markers, added: “Our expansion will provide the resources needed for regional scientific and medical experts to assemble and deliver high quality central review of imaging data for multisite trials in Europe.”

Related news

Show more

Related products

show more

The APAC Advantages

The APAC Advantages

Catalent Pharma Solutions | 18-Jan-2022 | Insight Guide

Over recent years, the Asia-Pacific (APAC) region has become an emerging market for pharmaceutical and biotech innovation, including clinical studies.

CellCarta - Mapping Precision Medicine

CellCarta - Mapping Precision Medicine

CellCarta | 17-Jan-2022 | Product Presentation

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Optimizing Processes for Modern Digital Trials

Optimizing Processes for Modern Digital Trials

eClinical Solutions | 12-Jan-2022 | Case Study

Modern digital trials have sparked a new need within life sciences organizations for optimized and scalable clinical data processes & strategies. This...

The Case for a Clinical Data Strategy

The Case for a Clinical Data Strategy

eClinical Solutions | 12-Jan-2022 | Technical / White Paper

Being data-driven is top-of-mind for many life sciences companies, but actually turning that idea into action is easier said than done. To effectively...

Related suppliers

Follow us


View more